Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures FTSE (0.33%), DAX (0.05%), CAC40 +0.15%

Jul 01 ,2026

  • Synopsis

    • European equity markets are set for a softer open amidst Asian equities mixed Wednesday. South Korea under pressure amid memory pullback.

    • Germany's Cabinet meets at the ministry of defense, with NATO's Rutte attending as a guest. A joint press conf. with Chancellor Merz, defence minister and NATO Secretary General is scheduled to follow. In the UK, after MPs question on Science, Innovation and Technology there's weekly PMQs at 12noon BST, whilst the Taxation (Energy and Vehicles) Bill continues its passage through parliament. Committee topics include managing the future of UK oil and gas at 13:45 and risks and opportunities to the sustainability of data centres in the UK at 14:30. EU's Kadis speech at the Committee of the Regions plenary debate on the Ocean Pact and EU's Šefčovič meets with UK's minister for the constitution and EU relations Thomas-Symonds. Also, stricter tariff rules for steel imports into the EU come into effect.

    • In central banks, BOE's Bailey panellist at 14:30BST at ECB Forum on Central Banking, with ECB's Lagarde, Vujcic, Cipollone and Lane also among the speakers/panellists. Elsewhere, Fitch Rating webinar at 14:00BST title European Banks in H2: Resilience Under Pressure, and France, Italy, Spain Jun new car registrations are due to be released.

    • A busy macro front with Italy, Spain, Sweden, Switzerland Jun manufacturing PMI as well as final reads for Eurozone, France, Germany, UK, Eurozone Jun flash CPI, Switzerland May retail sales, Netherlands Q1 final GDP, Jun preliminary CPI, May retail sales, Greece May Unemployment rate, Ireland Jun unemployment rate, Finland Jun preliminary HICP, Austria Jun preliminary CPI, unemployment rate, Portugal May unemployment rate

    • In M&A news, Schneider Electric (SU.FP) announced a definitive agreement to acquire 100% of Cognite Holding B.V. (AKER.NO) in an all-cash transaction valued at $3.1B. The transaction proceeds to Aker represents an uplift to the reported Net Asset Value (NAV) per Q1 2026 of NOK 7.4B or approximately NOK 100 per share. A light morning for earnings sees Biophytis (ALBPS.FP) out with FY results.

  • Politics/Macro/World News

    • Starmer trims budgets to fund extra £15bn for defence - BBC

    • Burnham left with £4.7bn bill for Starmer's new defence investment plan - Guardian

    • Netherlands Q1 GDP +1.4% y/y vs preliminary +1.2%

    • Netherlands May Retail Sales +2.9% y/y vs consensus +2.9% and prior +3.4%

    • Finland May Preliminary HICP +2.7% y/y vs consensus +3.1% and prior +2.8%

  • Top company news

    • Earnings/updates

      • ALBPS.FP (Biophytis) -- reports FY net income (€7.8M) vs FactSet (€34.5M) [1 est]

      • SBO.NO (Selvaag Bolig) -- sold 205 homes in Q2 for NOK 1.65B

      • AGR.AV (Agrana Beteiligungs) -- reports prelim Q1 EBIT €35.4M vs year-ago €5.7M; confirms FY26/27 guidance

    • M&A

      • COFB.BB (Cofinimmo) -- Aedifica completes merger by absorption of Cofinimmo

      • EDPR.PL (EDP Renovaveis) -- sells a 68 MWac (70 MWdc) wind and solar portfolio in Italy for ~ €150M

      • SHEL.LN (Shell Plc) -- to sell interest in Gulf of America platform & Coulomb tieback for total consideration of $1.7B

      • SU.FP (Schneider Electric) -- enters into definitive agreement to acquire 100% of Cognite Holding B.V. in an all-cash transaction valued at $3.1B

      • IPN.FP (Ipsen) -- to acquire Memo Therapeutics AG for €200M in cash plus deferred milestones for a total potential consideration in excess of €700M

      • FMC (FMC Corp) -- Tessenderlo Group to invest $400M in FMC Corp for ~20% stake at $13.30/share

      • PGHN.SW (Partners Group Holding) -- Partners Group invests in Avenue Capital Group's global commercial aviation leasing portfolio

      • WLN.FP (Worldline) -- Crédit Agricole acquires all shares held by the Worldline group in CAWL

      • CA.FP (Carrefour) -- completes sale of Romania to Paval Holding

      • SKA.B.SS (Skanska) -- divests rental multifamily project in Sollentuna, Sweden, for about SEK 570M

      • SDR.LN (Schroders) -- nearing sale of Benchmark Capital to Söderberg & Partners for more than £200M - FT

      • INRN.SW (Interroll Holding) -- acquires Interroll AS; terms undisclosed

    • Healthcare

      • 1AST.GR (ASTA Energy Solutions) -- signs Long-Term agreement (LTA) with ANDRITZ

      • ALCOX.FP (Nicox) -- NCX 470 New Drug Application Submitted in the United States by Kowa, with Associated €3M Milestone Payment

      • ALZCUR.SS (AlzeCure Pharma) -- enters into out-licensing and collaboration agreement with QuantumCell ApS regarding global rights to AlzeCure's Alzheimer's platform NeuroRestore, including leading drug candidate ACD856

      • ABVX.FP (Abivax) -- announces launch of public offering of ~$600M ADSs

      • TENX (Tenax Therapeutics) -- enters into amendment to license agreement with Orion Corporation - 8-K

      • IDIA.SW (Idorsia) -- appoints Roland Wandeler as CEO, effective 1-Oct-26

      • SANN.SW (Santhera Pharmaceuticals Holding) -- Santhera notes topline results from Catalyst Pharmaceuticals Phase 1 Clinical Study of AGAMREE

      • EMEIS.FP (Emeis SA) -- appoints Jean-Marc Boursier, Deputy CEO, as Chief Operating Officer effective 1-Sep-26

      • ATT.SS (Attendo) -- Martin Tivéus resigns as President and CEO of Attendo AB

    • Other

      • XK4.GR (Gabler Group) -- announces order with volume of ~ €17M

      • ABVX.FP (Abivax) -- announces temporary trading halt of its shares on Euronext Paris following ADS offering

      • SAN.FP (Sanofi) -- announces availability of aide-mémoire for Q2 2026 results

      • BMW.GR (Bayerische Motoren Werke) -- commences third tranche of share buyback of up to €625M

      • ATS.AV (AT & S) -- core owners selling €120M stake; offering by holders prices at €200/share -- Bloomberg

      • GALD.SW (Galderma) -- receives CRL from the FDA with comments regarding manufacturing site for RelabotulinumtoxinA

      • PIRC.IM (Pirelli & C.) -- Board majority nominated Marco Tronchetti Provera as Executive Chairman; board was informed of multi-year investment plan for the US of between ~ $1-1.2B

      • DTE.GR (Deutsche Telekom) -- to begin third tranche of 2026 share-buyback program today

      • SGSN.SW (SGS) -- Compass launches for data-driven global supply chain risk management and compliance

      • SAAB.B.SS (Saab) -- has today signed a contract with the Swedish Defence Materiel Administration (FMV) for 16 Gripen E fighter aircraft for Ukraine

      • GTT.FP (Gaztransport & Technigaz) -- receives order from Hudong-Zhonghua Shipbuilding for tank design of three new LNG carriers

      • KOG.NO (Kongsberg Gruppen) -- signs NOK 4.7B order for Joint Strike Missile

      • ECB weighing doubling minimum reserve requirements to 2% from 1% of banks' customer deposits - Reuters

      • Transocean Ltd. announces agreement with Equinor for the use of three of its harsh environment semisubmersible rigs on the Norwegian shelf valued at over $1B over 7 rig years

  • Key rating changes

    • Upgrades

      • AI.FP (Air Liquide) -- to buy from underperform at BofA

      • DIA.SM (Distribuidora Internacional De Alimentacion) -- to strong buy from buy at Alantra Equities

      • LUMO.FH (Lumo Homes) -- to buy from neutral at Goldman Sachs

      • TECN.SW (Tecan Group) -- to buy from neutral at UBS

      • WRT1V.FH (Wartsila) -- to neutral from underweight at JPMorgan

  • Data

    • Nikkei +0.87% to 70674.13

    • Hang Seng closed

    • Shanghai Composite +0.51% to 4115.10

    • S&P futures (20.0) vs prior close of 7548.3

    • €-$ (0.0018) or (0.16%) to 1.1406

    • $-¥ +0.12 or +0.08% to 162.70

    • €-¥ (0.14) or (0.08%) to 185.56

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.